Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas ...Middle East

HOUSTON, Dec. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug...

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas )

Also on site :

• ‘This is murder': Family remembers victims killed in Austin fire as 4th body recovered
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders
• RHOM star Larsa Pippen got ‘boob job, nose job, BBL and fillers’ to look like a ‘doll,’ top plastic surgeon claims